LOS ANGELES, Nov. 10, 2021 /PRNewswire/ -- Generate Life
Sciences® announces it has entered into an agreement to
be acquired by the publicly held healthcare company,
CooperCompanies (NYSE: COO) and become part of CooperSurgical, a
recognized global leader in women's health and fertility
solutions.
For over 40 years Generate has been helping to grow and protect
healthy families by providing reproductive, newborn stem cell
(umbilical cord blood and tissue) and related genetic
services. Bringing together Generate and Cooper will enable
additional growth given CooperSurgical's established network in
over 100 countries, providing greater access to Generate's
innovative science that promotes family wellness.
"Generate helps families around the world benefit from its
industry-leading services that support clients throughout their
reproductive journey, from pre-conception through post-birth," said
Generate CEO, Richard Jennings.
"Over the past several years, our company has transformed into a
global life sciences organization supporting clients looking to
build and protect their families. Our affiliation with GI Partners
was the catalyst to accelerate the growth of the
company."
Generate's suite of products and services complements the
current offerings of CooperSurgical in both fertility solutions and
labor & delivery. The combined business will provide fertility
clinics and healthcare providers with additional options to support
their patients during their assisted reproductive technology
treatment and beyond.
The transaction is subject to customary closing conditions,
including regulatory approval, with closing expected to occur in
Cooper's Fiscal first quarter.
About Generate Life Sciences
Generate Life
Sciences® ("Generate") is a life sciences company
helping to grow and protect families through reproductive, newborn
stem cell, genetic screening, medical device, and healthcare
technology services. The Company serves families from preconception
to post-birth. Its brands — CBR® (Cord Blood
Registry®), California Cryobank™, Donor Egg
Bank USA™, NW
Cryobank™, ReadyGen™, Kitazato USA™, and Donor
Application™ — are pioneering leaders that have helped
nearly one million families. Headquartered in Los Angeles, Generate operates facilities in
Tucson, New York, Boston, Palo
Alto, and Rockville, MD.
For more information, please visit www.generate.com.
About CooperCompanies
CooperCompanies ("Cooper") is a
global medical device company publicly traded on the NYSE (NYSE:
COO). Cooper operates through two business units, CooperVision and
CooperSurgical. CooperVision brings a refreshing perspective on
vision care with a commitment to developing a wide range of
high-quality products for contact lens wearers and providing
focused practitioner support. CooperSurgical is committed to
advancing the health of women, babies and families with its
diversified portfolio of products and services focusing on medical
devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more
than 12,000 with products sold in over 100 countries. For more
information, please visit www.coopercos.com.
Contact: Azeem Zeekrya,
azeem.zeekrya@hdmz.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/generate-life-sciences-to-be-acquired-by-coopercompanies-301421685.html
SOURCE Generate Life Sciences